122 related articles for article (PubMed ID: 21465075)
1. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
Fernández MA; Gebara E
Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
[TBL] [Abstract][Full Text] [Related]
2. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation.
Woo K; Emery J; Peabody J
Pediatrics; 1994 Mar; 93(3):417-20. PubMed ID: 8115200
[TBL] [Abstract][Full Text] [Related]
3. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK; Frayha HH; deMoor MM
Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
[TBL] [Abstract][Full Text] [Related]
4. Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review.
Velaphi S; Cilliers A; Beckh-Arnold E; Mokhachane M; Mphahlele R; Pettifor J
J Perinatol; 2004 Apr; 24(4):263-5. PubMed ID: 15067299
[TBL] [Abstract][Full Text] [Related]
5. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
Høst A; Halken S; Andersen PE
Pediatr Radiol; 1988; 18(2):149-53. PubMed ID: 3281113
[TBL] [Abstract][Full Text] [Related]
6. [Secondary effects of prostaglandin E1 on the management of hypoplastic left heart syndrome while waiting for heart transplantation].
Caballero S; Torre I; Arias B; Blanco D; Zabala JI; Sánchez Luna M
An Esp Pediatr; 1998 May; 48(5):505-9. PubMed ID: 9656538
[TBL] [Abstract][Full Text] [Related]
7. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin induced cortical hyperostosis in neonates with cyanotic heart disease.
Nadroo AM; Shringari S; Garg M; al-Sowailem AM
J Perinat Med; 2000; 28(6):447-52. PubMed ID: 11155430
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin-induced hyperostosis. A case report.
Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
[TBL] [Abstract][Full Text] [Related]
10. Side-effects of long-term prostaglandin E(1) treatment in neonates.
Tálosi G; Katona M; Túri S
Pediatr Int; 2007 Jun; 49(3):335-40. PubMed ID: 17532831
[TBL] [Abstract][Full Text] [Related]
11. Strategies for prolonged survival before heart transplantation in the neonatal intensive care unit.
Emery JR
J Heart Lung Transplant; 1993; 12(6 Pt 2):S161-3. PubMed ID: 8312329
[TBL] [Abstract][Full Text] [Related]
12. Cortical hyperostosis as a side-effect of prolonged use of prostaglandins.
Rivero Jiménez N; Bret-Zurita M; García-Guereta Silva L
Cardiol Young; 2016 Jan; 26(1):149-50. PubMed ID: 26423344
[TBL] [Abstract][Full Text] [Related]
13. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
[TBL] [Abstract][Full Text] [Related]
14. Cortical hyperostosis secondary to prostaglandin E1 therapy.
Estes K; Nowicki M; Bishop P
J Pediatr; 2007 Oct; 151(4):441, 441.e1. PubMed ID: 17889087
[No Abstract] [Full Text] [Related]
15. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
[TBL] [Abstract][Full Text] [Related]
16. Generalized periosteal reaction and tissue swelling secondary to prolonged prostaglandin E1 infusion and venous stasis: a case report.
Alan S; Uçar T; Erdeve O; Atasay B; Arsan S; Atalay S
Turk J Pediatr; 2013; 55(5):543-5. PubMed ID: 24382539
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease.
Aykanat A; Yavuz T; Özalkaya E; Topçuoğlu S; Ovalı F; Karatekin G
Pediatr Cardiol; 2016 Jan; 37(1):131-4. PubMed ID: 26260095
[TBL] [Abstract][Full Text] [Related]
19. Soft-tissue swelling in two neonates during prostaglandin E1 therapy.
Jureidini S; Chase NA; Alpert BS; Vanderzalm T; Sheneflet RE
Pediatr Cardiol; 1986; 7(3):157-60. PubMed ID: 3543871
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]